The objective of this Administrative Core (Core A) is to support the mission of the University of Pennsylvania (Penn) Alzheimer's Disease (AD) Core Center (ADCC) by facilitating efforts to increase research and understanding of AD and related disorders as well as mild cognitive impairment (MCI) and healthy aging at and beyond Penn. Core A also sets the direction ofthe ADCC, guides development of its programs, promotes interactions of its investigators with National Institute on Aging (NIA) funded AD Centers (ADCs), the National AD Coordinating Center (NACC), the AD Cooperative Study (ADCS), the AD Education and Referral (ADEAR) Center, the AD Neuroimaging Initiative (ADNI), the AD Genetics Consortium (ADGC) and other related NIH and public/private agency supported initiatives focused on AD and related disorders. Core A will accomplish these goals through five highly effective mechanisms. First, Core A provides fiscal and administrative oversight of the ADCC, and the ADCC Executive Committee meets regularly to review ADCC activities and address issues as they arise. Second, Pilot grant applications are solicited annually, and the ADCC Pilot Review Committee identifies 2 meritorious Pilots for funding each year by the ADCC as well as 1-3 additional Pilots funded by the Penn Institute on Aging (lOA) which partners with the ADCC in this Pilot program. Third, Core A organizes annual reviews ofthe Penn ADCC by the ADCC External Advisory Committee. Fourth, Core A facilitates participation of ADCC investigators in annual Penn-wide retreats held by the lOA and the Center for Neurodegenerative Disease Research (CNDR) for students, postdoctoral fellows and faculty from a wide range of disciplines in neuroscience and aging. Finally, Core A promotes interactions of the Penn ADCC with NACC, ADCS, ADEAR, ADNI, ADGC and other ADCs in education and research initiatives. Thus, Core A provides a clearly delineated administrative structure that enables the Penn ADCC to increase the quality and quantity of clinical and basic research as well as educational activities on AD and related disorders as well as MCI and normal aging at and beyond Penn.

Public Health Relevance

;Administrative Core A is highly relevant to the continued success of the Penn ADCC because it exercises fiscal and administrative oversight over this Center, facilitates interactions among ADCC investigators to accomplish the research conducted in programs linked to the Penn ADCC which is the foundational neurodegenerative disease program that has spawned/enabled other neurodegenerative disease research programs at Penn. Finally, Core A coordinates and integrates activities ofthe Cores, and provides mechanisms to advise the Principal Investigator and Core Leaders of this PPG on their progress towards accomplishing the goals of NIA funded ADCCs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010124-23
Application #
8501181
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
23
Fiscal Year
2013
Total Cost
$217,834
Indirect Cost
$81,688
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Akhtar, Rizwan S; Licata, Joseph P; Luk, Kelvin C et al. (2018) Measurements of auto-antibodies to ?-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease. J Neurochem 145:489-503
Rey, Nolwen L; George, Sonia; Steiner, Jennifer A et al. (2018) Spread of aggregates after olfactory bulb injection of ?-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65-83
Lee, Edward B (2018) Integrated neurodegenerative disease autopsy diagnosis. Acta Neuropathol 135:643-646
Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328
Tropea, Thomas F; Chen-Plotkin, Alice S (2018) Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease. Parkinsonism Relat Disord 46 Suppl 1:S15-S18
Alosco, Michael L; Tripodis, Yorghos; Fritts, Nathan G et al. (2018) Cerebrospinal fluid tau, A?, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement 14:1159-1170
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Alcolea, Daniel; Irwin, David J; Illán-Gala, Ignacio et al. (2018) Elevated YKL-40 and low sAPP?:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD. J Neurol Neurosurg Psychiatry :
Wenning, Gregor; Trojanowski, John Q; Kaufmann, Horacio et al. (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10-12

Showing the most recent 10 out of 720 publications